US Patent 11173159 Methods and compositions for inhibition of polymerase
Patent 11173159 was granted and assigned to BioCryst Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11173159 Methods and compositions for inhibition of polymerase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.